Atrys Health Past Earnings Performance
Past criteria checks 0/6
Atrys Health's earnings have been declining at an average annual rate of -62.6%, while the Healthcare industry saw earnings declining at 1.2% annually. Revenues have been growing at an average rate of 55.9% per year.
Key information
-62.6%
Earnings growth rate
-50.6%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 55.9% |
| Return on equity | -10.6% |
| Net Margin | -14.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Atrys Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 206 | -30 | 2 | 0 |
| 30 Jun 23 | 222 | -34 | 1 | 0 |
| 31 Mar 23 | 207 | -28 | 1 | 0 |
| 31 Dec 22 | 163 | -26 | 3 | 0 |
| 30 Sep 22 | 181 | -23 | 1 | 0 |
| 30 Jun 22 | 171 | -22 | 1 | 0 |
| 31 Mar 22 | 148 | -23 | 1 | 0 |
| 31 Dec 21 | 124 | -23 | 1 | 0 |
| 30 Sep 21 | 96 | -16 | 1 | 0 |
| 30 Jun 21 | 67 | -8 | 1 | 0 |
| 31 Mar 21 | 51 | -7 | 0 | 0 |
| 31 Dec 20 | 34 | -6 | 0 | 0 |
| 30 Sep 20 | 26 | -2 | 0 | 0 |
| 30 Jun 20 | 19 | -1 | 0 | 0 |
| 31 Mar 20 | 18 | -1 | 0 | 0 |
| 31 Dec 19 | 17 | 0 | 0 | 0 |
| 30 Sep 19 | 14 | 0 | 0 | 0 |
| 30 Jun 19 | 12 | 0 | 0 | 0 |
| 31 Mar 19 | 11 | 0 | 0 | 0 |
| 31 Dec 18 | 9 | 0 | 0 | 0 |
| 30 Sep 18 | 9 | 0 | 0 | 0 |
| 30 Jun 18 | 9 | 0 | 0 | 0 |
| 31 Mar 18 | 8 | 0 | 0 | 0 |
| 31 Dec 17 | 8 | 0 | 0 | 0 |
| 30 Sep 17 | 7 | 0 | 1 | 0 |
| 30 Jun 17 | 7 | 0 | 1 | 0 |
| 31 Mar 17 | 6 | 0 | 1 | 0 |
| 31 Dec 16 | 6 | 0 | 2 | 0 |
| 31 Dec 15 | 3 | 1 | 0 | 0 |
| 31 Dec 14 | 2 | 0 | 0 | 0 |
| 31 Dec 13 | 3 | 0 | 0 | 0 |
Quality Earnings: A2T is currently unprofitable.
Growing Profit Margin: A2T is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A2T is unprofitable, and losses have increased over the past 5 years at a rate of 62.6% per year.
Accelerating Growth: Unable to compare A2T's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A2T is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (9.9%).
Return on Equity
High ROE: A2T has a negative Return on Equity (-10.61%), as it is currently unprofitable.